Small Doses of Propofol, Droperidol, and Metoclopramide for the Prevention of Postoperative Nausea and Vomiting After Thyroidectomy

Abstract

OBJECTIVE: To evaluate the efficacy and safety of small doses of propofol, droperidol, and metoclopramide for the prevention of postoperative nausea and vomiting (PONV) after thyroidectomy. STUDY DESIGN: Prospective, randomized, double-blinded study. SETTING: University-affiliated teaching hospital. METHODS: In a randomized, double-blinded study, 90 patients (75 females) received propofol 0.5 mg/kg, droperidol 20 μg/kg, or metoclopramide 0.2 mg/kg intravenously (n = 30 in each group) at the end of surgery. A standardized general anesthetic technique was used. RESULTS: The incidence of PONV during the first 24 hours after anesthesia was recorded in 13%, 47%, and 50% of patients who had received propofol, droperidol, and metoclopramide, respectively ( P < 0.05; overall Fisher exact probability test). No clinically important adverse events were observed in any of the groups. CONCLUSION: Small dose (0.5 mg/kg) of propofol is more effective than droperidol or metoclopramide for the prevention of PONV after thyroidectomy.